YeeMeng personal page - To The Moon

YeeMeng

No personal profile

33Follow

12Followers

0Topic

0Badge

2021-09-23

Done

Boeing lifts China jet demand estimate over two decades to $1.47 trln

2021-09-21

Great news for Pfizer?

Sorry, the original content has been removed

2021-09-05

Yes! It's about time

Cathie Wood is pouring millions into these China tech stocks — time to follow?

2021-09-03

Palantir is long term

Sorry, the original content has been removed

2021-09-02

It's about time

Hong Kong: Shares extend gains at open

2021-08-31

Great ariticle, would you like to share it?

Sorry, the original content has been removed

2021-08-31

That's great

Sorry, the original content has been removed

2021-08-29

That's great

Yemen gets first batch of J&J COVID-19 vaccines

2021-08-26

Will turn around in soon

XPeng Q2 per-ADS loss RMB1.50 vs. loss RMB6.29 a year ago

2021-08-26

Something positive for a change. It's about time

Sorry, the original content has been removed

2021-08-23

Time to collect riot?

Sorry, the original content has been removed

2021-08-23

Accumulate

Vivos Therapeutics Stock Is Moving Higher On FDA Approval For Its Sleep Apnea Device

2021-08-22

Is it time to accumulate Baba?

Sorry, the original content has been removed

2021-08-20

Hope things will turn around

Sorry, the original content has been removed

2021-08-19

That's great

Apple stock price target raised to $180 from $175 at J.P. Morgan

2021-08-16

Great.

Sorry, the original content has been removed

2021-08-13

I am still bullish on Apple

Sorry, the original content has been removed

2021-08-12

Not an encouraging debut

Sorry, the original content has been removed

2021-08-11

About time to acquire china shares

Sorry, the original content has been removed

2021-08-09

Hoping for a quick rebound

Sorry, the original content has been removed

Go to Tiger App to see more news

Invest in Global Markets with Tiger Brokers!

Open App

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3582597737343890","uuid":"3582597737343890","gmtCreate":1619679854751,"gmtModify":1619679854751,"name":"YeeMeng","pinyin":"yeemeng","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":12,"headSize":33,"tweetSize":58,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.25","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.01.30","exceedPercentage":"60.27%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":863645847,"gmtCreate":1632390398489,"gmtModify":1676530770600,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582597737343890","idStr":"3582597737343890"},"themes":[],"htmlText":"Done","listText":"Done","text":"Done","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/863645847","repostId":"2169661726","repostType":4,"repost":{"id":"2169661726","kind":"news","pubTimestamp":1632388430,"share":"https://ttm.financial/m/news/2169661726?lang=&edition=full_marsco","pubTime":"2021-09-23 17:13","market":"us","language":"en","title":"Boeing lifts China jet demand estimate over two decades to $1.47 trln","url":"https://stock-news.laohu8.com/highlight/detail?id=2169661726","media":"Reuters","summary":"BEIJING, Sept 23 (Reuters) - Boeing Co raised its forecast slightly on Thursday for China's aircraft","content":"<p>BEIJING, Sept 23 (Reuters) - Boeing Co raised its forecast slightly on Thursday for China's aircraft demand for the next 20 years, betting on the country's quick rebound from COVID-19 and future growth in its budget airline sector and e-commerce.</p>\n<p>Chinese airlines will need 8,700 new airplanes through 2040, 1.2% higher than its previous prediction of 8,600 planes made last year. Those would be worth $1.47 trillion based on list prices, the U.S. planemaker said in a statement.</p>\n<p>The 1.2% increase contrasted with the 6.3% growth Boeing forecast last year, which made China a bright spot in the aviation market at the height of coronavirus lockdowns worldwide.</p>\n<p>Earlier this month, Boeing revised up long-term forecasts for global airplane demand on the back of a strong recovery in commercial air travel in domestic markets like the United States.</p>\n<p>\"There are promising opportunities to significantly expand international long-haul routes and air freight capacity,\" said Richard Wynne, managing director of China marketing at Boeing's commercial arm.</p>\n<p>\"Longer-term, there is the potential for low-cost carrier growth to further build on single-aisle demand.\"</p>\n<p>China's domestic aviation market, although still vulnerable to sporadic local COVID-19 outbreaks, has more or less rebounded to pre-COVID levels, but the country's borders remain virtually closed, with the number of international flights only 2% of pre-COVID levels.</p>\n<p>Boeing projected a need for nearly 6,500 new single-aisle airplanes over the next 20 years, while China's widebody fleet, including passenger and cargo models, will require 1,850 new planes, accounting for 20% of total deliveries.</p>\n<p>Air freight market has become a bright spot for Boeing in China as e-commerce demand booms, even as the U.S. planemaker struggles with sales of passenger jets due to trade tensions and the grounding of its 737 MAX.</p>\n<p>China's aviation authority, the first regulator to ground 737 MAX following two deadly crashes, has yet to approve the return of service for the aircraft in the country. China accounts for a quarter of Boeing's orders of all aircraft.</p>\n<p>China will also need nearly $1.8 trillion worth of commercial services for its aircraft fleet over the 20-year period, company said.</p>\n<p>(Reporting by Stella Qiu in Beijing and Jamie Freed in Sdyney; Editing by Jacqueline Wong and Muralikumar Anantharaman)</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Boeing lifts China jet demand estimate over two decades to $1.47 trln</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBoeing lifts China jet demand estimate over two decades to $1.47 trln\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-23 17:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/1-boeing-lifts-china-jet-050050256.html><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BEIJING, Sept 23 (Reuters) - Boeing Co raised its forecast slightly on Thursday for China's aircraft demand for the next 20 years, betting on the country's quick rebound from COVID-19 and future ...</p>\n\n<a href=\"https://finance.yahoo.com/news/1-boeing-lifts-china-jet-050050256.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BA":"波音"},"source_url":"https://finance.yahoo.com/news/1-boeing-lifts-china-jet-050050256.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2169661726","content_text":"BEIJING, Sept 23 (Reuters) - Boeing Co raised its forecast slightly on Thursday for China's aircraft demand for the next 20 years, betting on the country's quick rebound from COVID-19 and future growth in its budget airline sector and e-commerce.\nChinese airlines will need 8,700 new airplanes through 2040, 1.2% higher than its previous prediction of 8,600 planes made last year. Those would be worth $1.47 trillion based on list prices, the U.S. planemaker said in a statement.\nThe 1.2% increase contrasted with the 6.3% growth Boeing forecast last year, which made China a bright spot in the aviation market at the height of coronavirus lockdowns worldwide.\nEarlier this month, Boeing revised up long-term forecasts for global airplane demand on the back of a strong recovery in commercial air travel in domestic markets like the United States.\n\"There are promising opportunities to significantly expand international long-haul routes and air freight capacity,\" said Richard Wynne, managing director of China marketing at Boeing's commercial arm.\n\"Longer-term, there is the potential for low-cost carrier growth to further build on single-aisle demand.\"\nChina's domestic aviation market, although still vulnerable to sporadic local COVID-19 outbreaks, has more or less rebounded to pre-COVID levels, but the country's borders remain virtually closed, with the number of international flights only 2% of pre-COVID levels.\nBoeing projected a need for nearly 6,500 new single-aisle airplanes over the next 20 years, while China's widebody fleet, including passenger and cargo models, will require 1,850 new planes, accounting for 20% of total deliveries.\nAir freight market has become a bright spot for Boeing in China as e-commerce demand booms, even as the U.S. planemaker struggles with sales of passenger jets due to trade tensions and the grounding of its 737 MAX.\nChina's aviation authority, the first regulator to ground 737 MAX following two deadly crashes, has yet to approve the return of service for the aircraft in the country. China accounts for a quarter of Boeing's orders of all aircraft.\nChina will also need nearly $1.8 trillion worth of commercial services for its aircraft fleet over the 20-year period, company said.\n(Reporting by Stella Qiu in Beijing and Jamie Freed in Sdyney; Editing by Jacqueline Wong and Muralikumar Anantharaman)","news_type":1},"isVote":1,"tweetType":1,"viewCount":953,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":869008484,"gmtCreate":1632223362448,"gmtModify":1676530728006,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582597737343890","idStr":"3582597737343890"},"themes":[],"htmlText":"Great news for Pfizer?","listText":"Great news for Pfizer?","text":"Great news for Pfizer?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/869008484","repostId":"1157787805","repostType":4,"isVote":1,"tweetType":1,"viewCount":1335,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":814575406,"gmtCreate":1630852873605,"gmtModify":1676530406102,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582597737343890","idStr":"3582597737343890"},"themes":[],"htmlText":"Yes! It's about time","listText":"Yes! It's about time","text":"Yes! It's about time","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/814575406","repostId":"2164808914","repostType":4,"repost":{"id":"2164808914","kind":"news","pubTimestamp":1630777500,"share":"https://ttm.financial/m/news/2164808914?lang=&edition=full_marsco","pubTime":"2021-09-05 01:45","market":"us","language":"en","title":"Cathie Wood is pouring millions into these China tech stocks — time to follow?","url":"https://stock-news.laohu8.com/highlight/detail?id=2164808914","media":"MoneyWise","summary":"It’s been a whiplash 2021 for Chinese tech stocks.\nThe Nasdaq Golden Dragon China Index, which track","content":"<p><img src=\"https://static.tigerbbs.com/de23888c2d8d96cf650c99664dbb31b2\" tg-width=\"1800\" tg-height=\"800\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>It’s been a whiplash 2021 for Chinese tech stocks.</p>\n<p>The Nasdaq Golden Dragon China Index, which tracks 98 of the biggest Chinese companies listed in the U.S., hit a record high of 20,688 on Feb. 12. But the index has been walloped since then on concerns that China’s tech sector could soon be facing greater scrutiny and tighter regulations at the hands of the Chinese government.</p>\n<p>Cathie Wood, founder of Ark Invest, <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the planet’s most hyped investment management firms, was one of the many investors to dump her Chinese stocks in late July.</p>\n<p>Wood has since returned to the Chinese tech space, bolstering her company's holdings with several notable Chinese stocks.</p>\n<p>Let’s see which stocks received the ace investor's stamp of approval this time around.</p>\n<p><b>JD.com (JD)</b></p>\n<p>Wood made multiple purchases of JD.com stock in August, nabbing 59,000 shares of the e-commerce company to the Ark Fintech Innovation ETF (ARKF) and just under 165,000 for Ark’s Autonomous Technology and Robotics ETF (ARKQ).</p>\n<p>\"I'm not pessimistic about China in the longer run because I think they're a very entrepreneurial society,\" Wood told Bloomberg. \"Sure, the government is putting more rules and regulations in, but I don't think the government wants to stop growth and progress at all.\"</p>\n<p>It’s an interesting take, considering Wood said during a recent Ark webinar with investors that Chinese stocks “probably will remain down.\"</p>\n<p>But Wood obviously sees value in JD.com after the company reported a 26% increase in revenue and a 27% increase in its user base during the second quarter of 2021. It’s stock has risen more than 12% in the past month.</p>\n<p>As one of the largest retailers in China, JD.com provides companies access to one of the world’s largest cohorts of consumers. The firm’s revenue streams are bolstered by offering marketing, analytics, logistics and warehousing and financing services.</p>\n<p><b>Tencent (TCEHY)</b></p>\n<p>On Aug. 16, Ark dumped more than 171,000 shares in Chinese tech conglomerate Tencent. A little more than a week later, Wood snapped up almost 235,000 shares in the company and added them to ARKF. Tencent now makes up 1.24% of ARKF’s holdings.</p>\n<p>It’s been a rough few months for Tencent. The company was recently fined multiple times by the Chinese government for anti-competitive behavior and saw its share price fall by more than 30% in the last six months. Company president Martin Lau recently told investors that he expects government regulators to be quite busy cracking down on the country’s tech sector.</p>\n<p>“It will be coming from all different regulator entities,” Lau said during an Aug. 18 call. “We think that there will be quite a few [new measures] coming out.”</p>\n<p>But Tencent’s exposure to multiple growth industries, including video games, cloud computing and artificial intelligence, make it an intriguing bet for funds like ARKF. Impressive second quarter results — a year over year increase in net profit of 29%, a rise in fintech and business services revenue of 40% — brought investors flocking back to buy Tencent on the dip.</p>\n<p>Since Aug. 19, Tencent stock is up almost 18%.</p>\n<p><b>Pinduoduo (PDD)</b></p>\n<p><img src=\"https://static.tigerbbs.com/62ae26f45f976c695c466b80913ea47e\" tg-width=\"1200\" tg-height=\"500\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Ascannio / Shutterstock</p>\n<p>The largest agriculture-focused tech platform in China, Pinduoduo currently connects about 12 million farmers and distributors directly to consumers. The company recently pledged to invest approximately $1.5 billion into advancing agricultural technology for the country’s farmers.</p>\n<p>Between Pinduoduo’s business model and socially-conscious goals, Ark Invest appears to see a bright future for the company. In four transactions at the end of August, Ark added almost 208,000 shares to ARKF.</p>\n<p>“We believe that Pinduoduo's important role in modernizing China’s agriculture industry and alleviating poverty across Tier 2 and 3 cities is improving its relationship with the Chinese government relative to its competition,” Ark wrote in a note.</p>\n<p>With global demand for food on the rise, it makes sense that Wood would expect an agricultural play to pay off over the long run. But Ark’s investment in Pinduoduo is already paying off: The company’s stock is up almost 16% since Aug. 3.</p>\n<p><b>Unleash your inner Cathie</b></p>\n<p>Whether you see Chinese tech stocks as a short-term value play or a long-term investment in a sector too crucial to be over-regulated, you’ll need to get started somewhere.</p>\n<p>You’re probably already familiar with popular no-fee investment platforms, but there are several other digital platforms you can use to put your money to work.</p>\n<p>One even allows you to invest in a diversified portfolio using little more than the “spare change” left over from your everyday purchases.</p>\n<p>However you choose to invest your money, especially when it comes to volatile assets like Chinese tech stocks, just make sure you’re making an informed decision — one you can afford — and not just chasing the next flash in the pan.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood is pouring millions into these China tech stocks — time to follow?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood is pouring millions into these China tech stocks — time to follow?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-05 01:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/cathie-wood-pouring-millions-china-174500701.html><strong>MoneyWise</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s been a whiplash 2021 for Chinese tech stocks.\nThe Nasdaq Golden Dragon China Index, which tracks 98 of the biggest Chinese companies listed in the U.S., hit a record high of 20,688 on Feb. 12. ...</p>\n\n<a href=\"https://finance.yahoo.com/news/cathie-wood-pouring-millions-china-174500701.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKF":"ARK Fintech Innovation ETF","JD":"京东","PDD":"拼多多","CAAS":"中汽系统","ARKQ":"ARK Autonomous Technology & Robotics ETF"},"source_url":"https://finance.yahoo.com/news/cathie-wood-pouring-millions-china-174500701.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2164808914","content_text":"It’s been a whiplash 2021 for Chinese tech stocks.\nThe Nasdaq Golden Dragon China Index, which tracks 98 of the biggest Chinese companies listed in the U.S., hit a record high of 20,688 on Feb. 12. But the index has been walloped since then on concerns that China’s tech sector could soon be facing greater scrutiny and tighter regulations at the hands of the Chinese government.\nCathie Wood, founder of Ark Invest, one of the planet’s most hyped investment management firms, was one of the many investors to dump her Chinese stocks in late July.\nWood has since returned to the Chinese tech space, bolstering her company's holdings with several notable Chinese stocks.\nLet’s see which stocks received the ace investor's stamp of approval this time around.\nJD.com (JD)\nWood made multiple purchases of JD.com stock in August, nabbing 59,000 shares of the e-commerce company to the Ark Fintech Innovation ETF (ARKF) and just under 165,000 for Ark’s Autonomous Technology and Robotics ETF (ARKQ).\n\"I'm not pessimistic about China in the longer run because I think they're a very entrepreneurial society,\" Wood told Bloomberg. \"Sure, the government is putting more rules and regulations in, but I don't think the government wants to stop growth and progress at all.\"\nIt’s an interesting take, considering Wood said during a recent Ark webinar with investors that Chinese stocks “probably will remain down.\"\nBut Wood obviously sees value in JD.com after the company reported a 26% increase in revenue and a 27% increase in its user base during the second quarter of 2021. It’s stock has risen more than 12% in the past month.\nAs one of the largest retailers in China, JD.com provides companies access to one of the world’s largest cohorts of consumers. The firm’s revenue streams are bolstered by offering marketing, analytics, logistics and warehousing and financing services.\nTencent (TCEHY)\nOn Aug. 16, Ark dumped more than 171,000 shares in Chinese tech conglomerate Tencent. A little more than a week later, Wood snapped up almost 235,000 shares in the company and added them to ARKF. Tencent now makes up 1.24% of ARKF’s holdings.\nIt’s been a rough few months for Tencent. The company was recently fined multiple times by the Chinese government for anti-competitive behavior and saw its share price fall by more than 30% in the last six months. Company president Martin Lau recently told investors that he expects government regulators to be quite busy cracking down on the country’s tech sector.\n“It will be coming from all different regulator entities,” Lau said during an Aug. 18 call. “We think that there will be quite a few [new measures] coming out.”\nBut Tencent’s exposure to multiple growth industries, including video games, cloud computing and artificial intelligence, make it an intriguing bet for funds like ARKF. Impressive second quarter results — a year over year increase in net profit of 29%, a rise in fintech and business services revenue of 40% — brought investors flocking back to buy Tencent on the dip.\nSince Aug. 19, Tencent stock is up almost 18%.\nPinduoduo (PDD)\nAscannio / Shutterstock\nThe largest agriculture-focused tech platform in China, Pinduoduo currently connects about 12 million farmers and distributors directly to consumers. The company recently pledged to invest approximately $1.5 billion into advancing agricultural technology for the country’s farmers.\nBetween Pinduoduo’s business model and socially-conscious goals, Ark Invest appears to see a bright future for the company. In four transactions at the end of August, Ark added almost 208,000 shares to ARKF.\n“We believe that Pinduoduo's important role in modernizing China’s agriculture industry and alleviating poverty across Tier 2 and 3 cities is improving its relationship with the Chinese government relative to its competition,” Ark wrote in a note.\nWith global demand for food on the rise, it makes sense that Wood would expect an agricultural play to pay off over the long run. But Ark’s investment in Pinduoduo is already paying off: The company’s stock is up almost 16% since Aug. 3.\nUnleash your inner Cathie\nWhether you see Chinese tech stocks as a short-term value play or a long-term investment in a sector too crucial to be over-regulated, you’ll need to get started somewhere.\nYou’re probably already familiar with popular no-fee investment platforms, but there are several other digital platforms you can use to put your money to work.\nOne even allows you to invest in a diversified portfolio using little more than the “spare change” left over from your everyday purchases.\nHowever you choose to invest your money, especially when it comes to volatile assets like Chinese tech stocks, just make sure you’re making an informed decision — one you can afford — and not just chasing the next flash in the pan.","news_type":1},"isVote":1,"tweetType":1,"viewCount":929,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":815368327,"gmtCreate":1630645424869,"gmtModify":1676530365259,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582597737343890","idStr":"3582597737343890"},"themes":[],"htmlText":"Palantir is long term","listText":"Palantir is long term","text":"Palantir is long term","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/815368327","repostId":"1129167710","repostType":4,"isVote":1,"tweetType":1,"viewCount":907,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":812377169,"gmtCreate":1630558149851,"gmtModify":1676530340172,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582597737343890","idStr":"3582597737343890"},"themes":[],"htmlText":"It's about time","listText":"It's about time","text":"It's about time","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/812377169","repostId":"1105808841","repostType":4,"repost":{"id":"1105808841","kind":"news","pubTimestamp":1630547089,"share":"https://ttm.financial/m/news/1105808841?lang=&edition=full_marsco","pubTime":"2021-09-02 09:44","market":"hk","language":"en","title":"Hong Kong: Shares extend gains at open","url":"https://stock-news.laohu8.com/highlight/detail?id=1105808841","media":"AFP","summary":"[HONG KONG] Hong Kong stocks began with another advance on Thursday morning as investors bide their ","content":"<p>[HONG KONG] Hong Kong stocks began with another advance on Thursday morning as investors bide their time ahead of the release of key US jobs data at the end of the week.</p>\n<p>The Hang Seng Index rose 0.67 per cent or 175.23 points to 26,203.52.</p>\n<p>The Shanghai Composite dipped 0.20 per cent or 7.20 points to 3,559.90, while the Shenzhen Composite Index on China's second exchange fell 0.22 per cent or 5.32 points to 2,412.57.</p>","source":"lsy1605843958005","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong: Shares extend gains at open</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong: Shares extend gains at open\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-02 09:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.businesstimes.com.sg/stocks/hong-kong-shares-extend-gains-at-open-3><strong>AFP</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>[HONG KONG] Hong Kong stocks began with another advance on Thursday morning as investors bide their time ahead of the release of key US jobs data at the end of the week.\nThe Hang Seng Index rose 0.67 ...</p>\n\n<a href=\"https://www.businesstimes.com.sg/stocks/hong-kong-shares-extend-gains-at-open-3\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HSI":"恒生指数"},"source_url":"https://www.businesstimes.com.sg/stocks/hong-kong-shares-extend-gains-at-open-3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105808841","content_text":"[HONG KONG] Hong Kong stocks began with another advance on Thursday morning as investors bide their time ahead of the release of key US jobs data at the end of the week.\nThe Hang Seng Index rose 0.67 per cent or 175.23 points to 26,203.52.\nThe Shanghai Composite dipped 0.20 per cent or 7.20 points to 3,559.90, while the Shenzhen Composite Index on China's second exchange fell 0.22 per cent or 5.32 points to 2,412.57.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1393,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818218789,"gmtCreate":1630412879541,"gmtModify":1676530296020,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582597737343890","idStr":"3582597737343890"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/818218789","repostId":"1134100855","repostType":4,"isVote":1,"tweetType":1,"viewCount":1278,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818218568,"gmtCreate":1630412868854,"gmtModify":1676530296003,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582597737343890","idStr":"3582597737343890"},"themes":[],"htmlText":"That's great","listText":"That's great","text":"That's great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/818218568","repostId":"1134100855","repostType":4,"isVote":1,"tweetType":1,"viewCount":1371,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":813483489,"gmtCreate":1630229632541,"gmtModify":1676530247886,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582597737343890","idStr":"3582597737343890"},"themes":[],"htmlText":"That's great","listText":"That's great","text":"That's great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/813483489","repostId":"2163071215","repostType":2,"repost":{"id":"2163071215","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1630228826,"share":"https://ttm.financial/m/news/2163071215?lang=&edition=full_marsco","pubTime":"2021-08-29 17:20","market":"us","language":"en","title":"Yemen gets first batch of J&J COVID-19 vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=2163071215","media":"Reuters","summary":"ADEN, Aug 29 (Reuters) - Yemen received its first shipment of COVID-19 vaccines made by Johnson & Jo","content":"<html><body><p>ADEN, Aug 29 (Reuters) - Yemen received its first shipment of COVID-19 vaccines made by Johnson &amp; Johnson    on Sunday, roughly 151,000 doses, the health ministry said.</p><p>   The desperately poor country, where health infrastructure has been devastated by six years of war, received 360,000 doses of AstraZeneca's vaccine in March through COVAX.</p><p>   This shipment is the first batch of a total of 504,000 doses it is set to receive from the United States.</p><p>   The single-dose vaccines arrived as the United Nations warned early this month that Yemen, where only roughly 1% of the population is vaccinated, faces a third wave of COVID-19.</p><p>   The disease has killed 1,450 people in areas controlled by the internationally-recognised government of Yemen based in Aden, out of a total 7,751 recorded infections.</p><p>   The Iran-aligned Houthi movement, which is at war with the Aden-based government and controls the capital Sanaa as well as major cities in the north and west, has only announced four infections in areas it controls and <a href=\"https://laohu8.com/S/AONE.U\">one</a> death of a Somali immigrant in April 2020.</p><p>   Yemen is set to receive doses of the Oxford-AstraZeneca vaccine from COVAX next month.</p><p> (Reporting by Reyam Mukhashaf; Writing by Yousef Saba)</p><p>((Yousef.Saba@thomsonreuters.com; +971562166204; ))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Yemen gets first batch of J&J COVID-19 vaccines</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYemen gets first batch of J&J COVID-19 vaccines\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-08-29 17:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>ADEN, Aug 29 (Reuters) - Yemen received its first shipment of COVID-19 vaccines made by Johnson &amp; Johnson    on Sunday, roughly 151,000 doses, the health ministry said.</p><p>   The desperately poor country, where health infrastructure has been devastated by six years of war, received 360,000 doses of AstraZeneca's vaccine in March through COVAX.</p><p>   This shipment is the first batch of a total of 504,000 doses it is set to receive from the United States.</p><p>   The single-dose vaccines arrived as the United Nations warned early this month that Yemen, where only roughly 1% of the population is vaccinated, faces a third wave of COVID-19.</p><p>   The disease has killed 1,450 people in areas controlled by the internationally-recognised government of Yemen based in Aden, out of a total 7,751 recorded infections.</p><p>   The Iran-aligned Houthi movement, which is at war with the Aden-based government and controls the capital Sanaa as well as major cities in the north and west, has only announced four infections in areas it controls and <a href=\"https://laohu8.com/S/AONE.U\">one</a> death of a Somali immigrant in April 2020.</p><p>   Yemen is set to receive doses of the Oxford-AstraZeneca vaccine from COVAX next month.</p><p> (Reporting by Reyam Mukhashaf; Writing by Yousef Saba)</p><p>((Yousef.Saba@thomsonreuters.com; +971562166204; ))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2163071215","content_text":"ADEN, Aug 29 (Reuters) - Yemen received its first shipment of COVID-19 vaccines made by Johnson & Johnson    on Sunday, roughly 151,000 doses, the health ministry said.   The desperately poor country, where health infrastructure has been devastated by six years of war, received 360,000 doses of AstraZeneca's vaccine in March through COVAX.   This shipment is the first batch of a total of 504,000 doses it is set to receive from the United States.   The single-dose vaccines arrived as the United Nations warned early this month that Yemen, where only roughly 1% of the population is vaccinated, faces a third wave of COVID-19.   The disease has killed 1,450 people in areas controlled by the internationally-recognised government of Yemen based in Aden, out of a total 7,751 recorded infections.   The Iran-aligned Houthi movement, which is at war with the Aden-based government and controls the capital Sanaa as well as major cities in the north and west, has only announced four infections in areas it controls and one death of a Somali immigrant in April 2020.   Yemen is set to receive doses of the Oxford-AstraZeneca vaccine from COVAX next month. (Reporting by Reyam Mukhashaf; Writing by Yousef Saba)((Yousef.Saba@thomsonreuters.com; +971562166204; ))","news_type":1},"isVote":1,"tweetType":1,"viewCount":517,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810629262,"gmtCreate":1629973390256,"gmtModify":1676530188529,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582597737343890","idStr":"3582597737343890"},"themes":[],"htmlText":"Will turn around in soon","listText":"Will turn around in soon","text":"Will turn around in soon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/810629262","repostId":"2162093191","repostType":2,"repost":{"id":"2162093191","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1629972060,"share":"https://ttm.financial/m/news/2162093191?lang=&edition=full_marsco","pubTime":"2021-08-26 18:01","market":"hk","language":"en","title":"XPeng Q2 per-ADS loss RMB1.50 vs. loss RMB6.29 a year ago","url":"https://stock-news.laohu8.com/highlight/detail?id=2162093191","media":"Dow Jones","summary":"MW XPeng Q2 per-ADS loss RMB1.50 vs. loss RMB6.29 a year ago\n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  A","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW XPeng Q2 per-ADS loss RMB1.50 vs. loss RMB6.29 a year ago\n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  August 26, 2021 06:01 ET (10:01 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>XPeng Q2 per-ADS loss RMB1.50 vs. loss RMB6.29 a year ago</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXPeng Q2 per-ADS loss RMB1.50 vs. loss RMB6.29 a year ago\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-08-26 18:01</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW XPeng Q2 per-ADS loss RMB1.50 vs. loss RMB6.29 a year ago\n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  August 26, 2021 06:01 ET (10:01 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QTWO":"Q2 Holdings Inc","XPEV":"小鹏汽车"},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162093191","content_text":"MW XPeng Q2 per-ADS loss RMB1.50 vs. loss RMB6.29 a year ago\n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  August 26, 2021 06:01 ET (10:01 GMT)\n\n\n  Copyright (c) 2021 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":798,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810620471,"gmtCreate":1629973353693,"gmtModify":1676530188505,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582597737343890","idStr":"3582597737343890"},"themes":[],"htmlText":"Something positive for a change. It's about time","listText":"Something positive for a change. It's about time","text":"Something positive for a change. It's about time","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/810620471","repostId":"2162257093","repostType":2,"isVote":1,"tweetType":1,"viewCount":894,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":835262870,"gmtCreate":1629721663490,"gmtModify":1676530110838,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582597737343890","idStr":"3582597737343890"},"themes":[],"htmlText":"Time to collect riot?","listText":"Time to collect riot?","text":"Time to collect riot?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/835262870","repostId":"1141714591","repostType":4,"isVote":1,"tweetType":1,"viewCount":369,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":835268267,"gmtCreate":1629721516759,"gmtModify":1676530110802,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582597737343890","idStr":"3582597737343890"},"themes":[],"htmlText":"Accumulate","listText":"Accumulate","text":"Accumulate","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/835268267","repostId":"1102999278","repostType":4,"repost":{"id":"1102999278","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1629721328,"share":"https://ttm.financial/m/news/1102999278?lang=&edition=full_marsco","pubTime":"2021-08-23 20:22","market":"us","language":"en","title":"Vivos Therapeutics Stock Is Moving Higher On FDA Approval For Its Sleep Apnea Device","url":"https://stock-news.laohu8.com/highlight/detail?id=1102999278","media":"Benzinga","summary":"The FDA has granted 510(k) clearance to Vivos Therapeutics Inc's mmRNA (modified mandibular Repositi","content":"<p>The&nbsp;FDA has granted 510(k) clearance&nbsp;to&nbsp;<b><a href=\"https://laohu8.com/S/VVOS\">Vivos Therapeutics</a> Inc's</b>&nbsp;mmRNA (modified mandibular Repositioning Nighttime Appliance) obstructive sleep apnea (OSA) device.</p>\n<p>The device is indicated for mild to moderate OSA, sleep-disordered breathing, and snoring in adults.</p>\n<p>The approval paves the way for expanded insurance reimbursement coverage for the mmRNA device and potential future government contracts and reimbursement.</p>\n<p>Separately, the FDA has denied Vivos' previously submitted, additional 510(k) application for its DNA appliance.</p>\n<p>The DNA appliance is already registered with the FDA as a Class I device for palatal expansion and is currently being used by Vivos-trained clinicians accordingly.</p>\n<p>Vivos expects to appeal the FDA's decision or resubmit the 510(k) application to the FDA in the coming weeks.</p>\n<p><b>Price Action:</b>&nbsp;VVOS shares are up 41.9% at $5.45 during the premarket session on the last check Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vivos Therapeutics Stock Is Moving Higher On FDA Approval For Its Sleep Apnea Device</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVivos Therapeutics Stock Is Moving Higher On FDA Approval For Its Sleep Apnea Device\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-08-23 20:22</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>The&nbsp;FDA has granted 510(k) clearance&nbsp;to&nbsp;<b><a href=\"https://laohu8.com/S/VVOS\">Vivos Therapeutics</a> Inc's</b>&nbsp;mmRNA (modified mandibular Repositioning Nighttime Appliance) obstructive sleep apnea (OSA) device.</p>\n<p>The device is indicated for mild to moderate OSA, sleep-disordered breathing, and snoring in adults.</p>\n<p>The approval paves the way for expanded insurance reimbursement coverage for the mmRNA device and potential future government contracts and reimbursement.</p>\n<p>Separately, the FDA has denied Vivos' previously submitted, additional 510(k) application for its DNA appliance.</p>\n<p>The DNA appliance is already registered with the FDA as a Class I device for palatal expansion and is currently being used by Vivos-trained clinicians accordingly.</p>\n<p>Vivos expects to appeal the FDA's decision or resubmit the 510(k) application to the FDA in the coming weeks.</p>\n<p><b>Price Action:</b>&nbsp;VVOS shares are up 41.9% at $5.45 during the premarket session on the last check Monday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VVOS":"Vivos Therapeutics"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102999278","content_text":"The FDA has granted 510(k) clearance to Vivos Therapeutics Inc's mmRNA (modified mandibular Repositioning Nighttime Appliance) obstructive sleep apnea (OSA) device.\nThe device is indicated for mild to moderate OSA, sleep-disordered breathing, and snoring in adults.\nThe approval paves the way for expanded insurance reimbursement coverage for the mmRNA device and potential future government contracts and reimbursement.\nSeparately, the FDA has denied Vivos' previously submitted, additional 510(k) application for its DNA appliance.\nThe DNA appliance is already registered with the FDA as a Class I device for palatal expansion and is currently being used by Vivos-trained clinicians accordingly.\nVivos expects to appeal the FDA's decision or resubmit the 510(k) application to the FDA in the coming weeks.\nPrice Action: VVOS shares are up 41.9% at $5.45 during the premarket session on the last check Monday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":348,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":832634585,"gmtCreate":1629617471047,"gmtModify":1676530080837,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582597737343890","idStr":"3582597737343890"},"themes":[],"htmlText":"Is it time to accumulate Baba?","listText":"Is it time to accumulate Baba?","text":"Is it time to accumulate Baba?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/832634585","repostId":"1133515985","repostType":4,"isVote":1,"tweetType":1,"viewCount":220,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":836113483,"gmtCreate":1629464135442,"gmtModify":1676530049226,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582597737343890","idStr":"3582597737343890"},"themes":[],"htmlText":"Hope things will turn around","listText":"Hope things will turn around","text":"Hope things will turn around","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/836113483","repostId":"1136525529","repostType":4,"isVote":1,"tweetType":1,"viewCount":266,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":838354297,"gmtCreate":1629377275019,"gmtModify":1676530020394,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582597737343890","idStr":"3582597737343890"},"themes":[],"htmlText":"That's great","listText":"That's great","text":"That's great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/838354297","repostId":"2160769400","repostType":2,"repost":{"id":"2160769400","kind":"highlight","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1629372180,"share":"https://ttm.financial/m/news/2160769400?lang=&edition=full_marsco","pubTime":"2021-08-19 19:23","market":"hk","language":"en","title":"Apple stock price target raised to $180 from $175 at J.P. Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2160769400","media":"Dow Jones","summary":"MW Apple stock price target raised to $180 from $175 at J.P. Morgan\n\n\n \n\n\n$(END)$ Dow Jones Newswire","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW Apple stock price target raised to $180 from $175 at J.P. Morgan\n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  August 19, 2021 07:23 ET (11:23 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple stock price target raised to $180 from $175 at J.P. Morgan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple stock price target raised to $180 from $175 at J.P. Morgan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-08-19 19:23</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW Apple stock price target raised to $180 from $175 at J.P. Morgan\n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  August 19, 2021 07:23 ET (11:23 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2160769400","content_text":"MW Apple stock price target raised to $180 from $175 at J.P. Morgan\n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  August 19, 2021 07:23 ET (11:23 GMT)\n\n\n  Copyright (c) 2021 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":217,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":839921424,"gmtCreate":1629118097168,"gmtModify":1676529935773,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582597737343890","idStr":"3582597737343890"},"themes":[],"htmlText":"Great.","listText":"Great.","text":"Great.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/839921424","repostId":"2159863223","repostType":4,"isVote":1,"tweetType":1,"viewCount":330,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":894207261,"gmtCreate":1628826395453,"gmtModify":1676529867416,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582597737343890","idStr":"3582597737343890"},"themes":[],"htmlText":"I am still bullish on Apple","listText":"I am still bullish on Apple","text":"I am still bullish on Apple","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/894207261","repostId":"2159261473","repostType":4,"isVote":1,"tweetType":1,"viewCount":235,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":895408617,"gmtCreate":1628761623739,"gmtModify":1676529845787,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582597737343890","idStr":"3582597737343890"},"themes":[],"htmlText":"Not an encouraging debut","listText":"Not an encouraging debut","text":"Not an encouraging debut","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/895408617","repostId":"1145397172","repostType":4,"isVote":1,"tweetType":1,"viewCount":384,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3577178099298017","authorId":"3577178099298017","name":"DragonKC","avatar":"https://static.tigerbbs.com/f90c63c67a4e5f91e9dc0159f5b853ab","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3577178099298017","idStr":"3577178099298017"},"content":"Desperate for funding.","text":"Desperate for funding.","html":"Desperate for funding."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":892405083,"gmtCreate":1628679772042,"gmtModify":1676529818569,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582597737343890","idStr":"3582597737343890"},"themes":[],"htmlText":"About time to acquire china shares","listText":"About time to acquire china shares","text":"About time to acquire china shares","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/892405083","repostId":"2158417432","repostType":2,"isVote":1,"tweetType":1,"viewCount":403,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898495620,"gmtCreate":1628516326560,"gmtModify":1703507392116,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582597737343890","idStr":"3582597737343890"},"themes":[],"htmlText":"Hoping for a quick rebound","listText":"Hoping for a quick rebound","text":"Hoping for a quick rebound","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/898495620","repostId":"1166983029","repostType":4,"isVote":1,"tweetType":1,"viewCount":234,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":869008484,"gmtCreate":1632223362448,"gmtModify":1676530728006,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582597737343890","authorIdStr":"3582597737343890"},"themes":[],"htmlText":"Great news for Pfizer?","listText":"Great news for Pfizer?","text":"Great news for Pfizer?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/869008484","repostId":"1157787805","repostType":4,"repost":{"id":"1157787805","kind":"news","pubTimestamp":1632222985,"share":"https://ttm.financial/m/news/1157787805?lang=&edition=full_marsco","pubTime":"2021-09-21 19:16","market":"us","language":"en","title":"J&J Says Covid-19 Vaccine Booster Two Months After First Shot Increases Protection","url":"https://stock-news.laohu8.com/highlight/detail?id=1157787805","media":"The Wall Street Journal","summary":"Trial participants in the U.S. who received a second dose eight weeks after the first had 94% protec","content":"<blockquote>\n <b>Trial participants in the U.S. who received a second dose eight weeks after the first had 94% protection against the illness.</b>\n</blockquote>\n<p>Johnson &amp; JohnsonJNJ-0.57%said a booster dose of its Covid-19 vaccine administered two months after the first shot increased protection against symptomatic illness in trial participants, as federal regulators evaluate data for the country’s strategy for rolling out boosters.</p>\n<p>Data released Tuesday from a late-stage clinical trial showed that study participants in 10 countries including the U.S. who received a second dose of the company’s vaccine two months after the first had 75% protection against symptomatic Covid-19. Participants in the U.S. had 94% protection against the illness. J&amp;J didn’t explain the reason for the difference in efficacy rates.</p>\n<p>A double dose of the vaccine provided participants with 100% protection against severe or critical Covid-19 at least two weeks after the second shot, J&amp;J said.</p>\n<p>The company earlier this year said a large clinical trial showed thata single dose of its vaccine was 66% effectiveat protecting people from moderate to severe Covid-19.</p>\n<p>“We now have generated evidence that a booster shot further increases protection against Covid-19 and is expected to extend the duration of protection significantly,” said Paul Stoffels, chief scientific officer at J&amp;J. The company said it has shared available data with the Food and Drug Administration.</p>\n<p>The late-stage study tested a two-dose regimen of the vaccine in about 32,000 people aged 18 and over in the U.S., Belgium, Brazil, Colombia, France, Germany, the Philippines, South Africa, Spain and the U.K., J&amp;J said. The company said about half of participants received the placebo but didn’t say how many participants were in the U.S.</p>\n<p>J&amp;J said Tuesday that an extra shot given two months after the firstboosted antibody levels four to six times higherthan observed after the single shot. It said a booster administered six months after the first shot initially increased antibody levels ninefold and continued to climb to 12-fold higher four weeks after the second shot. J&amp;J released some of thesix-month boosting datain August.</p>\n<p>Neither that data nor the results released Tuesday have been peer reviewed or published in a scientific journal.</p>\n<p>“The data are supportive of giving a second shot of the J&amp;J vaccine, anywhere from two months onwards,” said Dan Barouch, an immunologist at Beth Israel Deaconess Medical Center in Boston who helped develop J&amp;J’s vaccine. “The longer you wait, the better the boost will likely be.”</p>\n<p>He said some countries might choose to offer boosters, while others might stick with a single shot. “Different people or different countries might actually make different choices based on what their desires or needs are,” Dr. Barouch said.</p>\n<p>J&amp;J also highlighted data it said showed its single-shot vaccine offered durable protectioneven as the Delta variant spreads.</p>\n<p>In a study of about 390,000 people in the U.S. who received the J&amp;J vaccine compared with 1.52 million similar unvaccinated people from March to late July 2021,the single-dose vaccine was 79% effectiveagainst infections and 81% effective against hospitalizations related to Covid-19.</p>\n<p>The Biden administration is hoping to begin at least part of its boosting strategy this week. It is waiting for the FDA to authorize additional doses of the vaccine fromPfizerInc.andBioNTech SEfor people who are 65 years old and over or at high risk of developing severe Covid-19. A Centers for Disease Control and Prevention advisory panel is set to discuss the Pfizer boosting strategy on Wednesday and Thursday.</p>\n<p>Plans to offer boosters more widely were scaled back as federal health officials and medical expertsremain divided over the need for boostersand regulators have asked for more time to review data from J&amp;J andModernaInc.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>J&J Says Covid-19 Vaccine Booster Two Months After First Shot Increases Protection</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJ&J Says Covid-19 Vaccine Booster Two Months After First Shot Increases Protection\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 19:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/j-j-says-covid-19-vaccine-booster-two-months-after-first-shot-increases-protection-11632220201?mod=hp_lead_pos3><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Trial participants in the U.S. who received a second dose eight weeks after the first had 94% protection against the illness.\n\nJohnson & JohnsonJNJ-0.57%said a booster dose of its Covid-19 vaccine ...</p>\n\n<a href=\"https://www.wsj.com/articles/j-j-says-covid-19-vaccine-booster-two-months-after-first-shot-increases-protection-11632220201?mod=hp_lead_pos3\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"source_url":"https://www.wsj.com/articles/j-j-says-covid-19-vaccine-booster-two-months-after-first-shot-increases-protection-11632220201?mod=hp_lead_pos3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157787805","content_text":"Trial participants in the U.S. who received a second dose eight weeks after the first had 94% protection against the illness.\n\nJohnson & JohnsonJNJ-0.57%said a booster dose of its Covid-19 vaccine administered two months after the first shot increased protection against symptomatic illness in trial participants, as federal regulators evaluate data for the country’s strategy for rolling out boosters.\nData released Tuesday from a late-stage clinical trial showed that study participants in 10 countries including the U.S. who received a second dose of the company’s vaccine two months after the first had 75% protection against symptomatic Covid-19. Participants in the U.S. had 94% protection against the illness. J&J didn’t explain the reason for the difference in efficacy rates.\nA double dose of the vaccine provided participants with 100% protection against severe or critical Covid-19 at least two weeks after the second shot, J&J said.\nThe company earlier this year said a large clinical trial showed thata single dose of its vaccine was 66% effectiveat protecting people from moderate to severe Covid-19.\n“We now have generated evidence that a booster shot further increases protection against Covid-19 and is expected to extend the duration of protection significantly,” said Paul Stoffels, chief scientific officer at J&J. The company said it has shared available data with the Food and Drug Administration.\nThe late-stage study tested a two-dose regimen of the vaccine in about 32,000 people aged 18 and over in the U.S., Belgium, Brazil, Colombia, France, Germany, the Philippines, South Africa, Spain and the U.K., J&J said. The company said about half of participants received the placebo but didn’t say how many participants were in the U.S.\nJ&J said Tuesday that an extra shot given two months after the firstboosted antibody levels four to six times higherthan observed after the single shot. It said a booster administered six months after the first shot initially increased antibody levels ninefold and continued to climb to 12-fold higher four weeks after the second shot. J&J released some of thesix-month boosting datain August.\nNeither that data nor the results released Tuesday have been peer reviewed or published in a scientific journal.\n“The data are supportive of giving a second shot of the J&J vaccine, anywhere from two months onwards,” said Dan Barouch, an immunologist at Beth Israel Deaconess Medical Center in Boston who helped develop J&J’s vaccine. “The longer you wait, the better the boost will likely be.”\nHe said some countries might choose to offer boosters, while others might stick with a single shot. “Different people or different countries might actually make different choices based on what their desires or needs are,” Dr. Barouch said.\nJ&J also highlighted data it said showed its single-shot vaccine offered durable protectioneven as the Delta variant spreads.\nIn a study of about 390,000 people in the U.S. who received the J&J vaccine compared with 1.52 million similar unvaccinated people from March to late July 2021,the single-dose vaccine was 79% effectiveagainst infections and 81% effective against hospitalizations related to Covid-19.\nThe Biden administration is hoping to begin at least part of its boosting strategy this week. It is waiting for the FDA to authorize additional doses of the vaccine fromPfizerInc.andBioNTech SEfor people who are 65 years old and over or at high risk of developing severe Covid-19. A Centers for Disease Control and Prevention advisory panel is set to discuss the Pfizer boosting strategy on Wednesday and Thursday.\nPlans to offer boosters more widely were scaled back as federal health officials and medical expertsremain divided over the need for boostersand regulators have asked for more time to review data from J&J andModernaInc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1335,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898495620,"gmtCreate":1628516326560,"gmtModify":1703507392116,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582597737343890","authorIdStr":"3582597737343890"},"themes":[],"htmlText":"Hoping for a quick rebound","listText":"Hoping for a quick rebound","text":"Hoping for a quick rebound","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/898495620","repostId":"1166983029","repostType":4,"isVote":1,"tweetType":1,"viewCount":234,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":803757029,"gmtCreate":1627467298461,"gmtModify":1703490516788,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582597737343890","authorIdStr":"3582597737343890"},"themes":[],"htmlText":"Buy on dips","listText":"Buy on dips","text":"Buy on dips","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/803757029","repostId":"2154405999","repostType":4,"isVote":1,"tweetType":1,"viewCount":322,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":801541970,"gmtCreate":1627524768890,"gmtModify":1703491653374,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582597737343890","authorIdStr":"3582597737343890"},"themes":[],"htmlText":"Fortune favours the brave","listText":"Fortune favours the brave","text":"Fortune favours the brave","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/801541970","repostId":"2155097100","repostType":4,"isVote":1,"tweetType":1,"viewCount":257,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":174418719,"gmtCreate":1627124955331,"gmtModify":1703484577004,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582597737343890","authorIdStr":"3582597737343890"},"themes":[],"htmlText":"I am still positive in Chinese stocks&nbsp; with a long term view","listText":"I am still positive in Chinese stocks&nbsp; with a long term view","text":"I am still positive in Chinese stocks with a long term view","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/174418719","repostId":"1151500518","repostType":4,"isVote":1,"tweetType":1,"viewCount":266,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":863645847,"gmtCreate":1632390398489,"gmtModify":1676530770600,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582597737343890","authorIdStr":"3582597737343890"},"themes":[],"htmlText":"Done","listText":"Done","text":"Done","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/863645847","repostId":"2169661726","repostType":4,"isVote":1,"tweetType":1,"viewCount":953,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":814575406,"gmtCreate":1630852873605,"gmtModify":1676530406102,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582597737343890","authorIdStr":"3582597737343890"},"themes":[],"htmlText":"Yes! It's about time","listText":"Yes! It's about time","text":"Yes! It's about time","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/814575406","repostId":"2164808914","repostType":4,"repost":{"id":"2164808914","kind":"news","pubTimestamp":1630777500,"share":"https://ttm.financial/m/news/2164808914?lang=&edition=full_marsco","pubTime":"2021-09-05 01:45","market":"us","language":"en","title":"Cathie Wood is pouring millions into these China tech stocks — time to follow?","url":"https://stock-news.laohu8.com/highlight/detail?id=2164808914","media":"MoneyWise","summary":"It’s been a whiplash 2021 for Chinese tech stocks.\nThe Nasdaq Golden Dragon China Index, which track","content":"<p><img src=\"https://static.tigerbbs.com/de23888c2d8d96cf650c99664dbb31b2\" tg-width=\"1800\" tg-height=\"800\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>It’s been a whiplash 2021 for Chinese tech stocks.</p>\n<p>The Nasdaq Golden Dragon China Index, which tracks 98 of the biggest Chinese companies listed in the U.S., hit a record high of 20,688 on Feb. 12. But the index has been walloped since then on concerns that China’s tech sector could soon be facing greater scrutiny and tighter regulations at the hands of the Chinese government.</p>\n<p>Cathie Wood, founder of Ark Invest, <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the planet’s most hyped investment management firms, was one of the many investors to dump her Chinese stocks in late July.</p>\n<p>Wood has since returned to the Chinese tech space, bolstering her company's holdings with several notable Chinese stocks.</p>\n<p>Let’s see which stocks received the ace investor's stamp of approval this time around.</p>\n<p><b>JD.com (JD)</b></p>\n<p>Wood made multiple purchases of JD.com stock in August, nabbing 59,000 shares of the e-commerce company to the Ark Fintech Innovation ETF (ARKF) and just under 165,000 for Ark’s Autonomous Technology and Robotics ETF (ARKQ).</p>\n<p>\"I'm not pessimistic about China in the longer run because I think they're a very entrepreneurial society,\" Wood told Bloomberg. \"Sure, the government is putting more rules and regulations in, but I don't think the government wants to stop growth and progress at all.\"</p>\n<p>It’s an interesting take, considering Wood said during a recent Ark webinar with investors that Chinese stocks “probably will remain down.\"</p>\n<p>But Wood obviously sees value in JD.com after the company reported a 26% increase in revenue and a 27% increase in its user base during the second quarter of 2021. It’s stock has risen more than 12% in the past month.</p>\n<p>As one of the largest retailers in China, JD.com provides companies access to one of the world’s largest cohorts of consumers. The firm’s revenue streams are bolstered by offering marketing, analytics, logistics and warehousing and financing services.</p>\n<p><b>Tencent (TCEHY)</b></p>\n<p>On Aug. 16, Ark dumped more than 171,000 shares in Chinese tech conglomerate Tencent. A little more than a week later, Wood snapped up almost 235,000 shares in the company and added them to ARKF. Tencent now makes up 1.24% of ARKF’s holdings.</p>\n<p>It’s been a rough few months for Tencent. The company was recently fined multiple times by the Chinese government for anti-competitive behavior and saw its share price fall by more than 30% in the last six months. Company president Martin Lau recently told investors that he expects government regulators to be quite busy cracking down on the country’s tech sector.</p>\n<p>“It will be coming from all different regulator entities,” Lau said during an Aug. 18 call. “We think that there will be quite a few [new measures] coming out.”</p>\n<p>But Tencent’s exposure to multiple growth industries, including video games, cloud computing and artificial intelligence, make it an intriguing bet for funds like ARKF. Impressive second quarter results — a year over year increase in net profit of 29%, a rise in fintech and business services revenue of 40% — brought investors flocking back to buy Tencent on the dip.</p>\n<p>Since Aug. 19, Tencent stock is up almost 18%.</p>\n<p><b>Pinduoduo (PDD)</b></p>\n<p><img src=\"https://static.tigerbbs.com/62ae26f45f976c695c466b80913ea47e\" tg-width=\"1200\" tg-height=\"500\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\">Ascannio / Shutterstock</p>\n<p>The largest agriculture-focused tech platform in China, Pinduoduo currently connects about 12 million farmers and distributors directly to consumers. The company recently pledged to invest approximately $1.5 billion into advancing agricultural technology for the country’s farmers.</p>\n<p>Between Pinduoduo’s business model and socially-conscious goals, Ark Invest appears to see a bright future for the company. In four transactions at the end of August, Ark added almost 208,000 shares to ARKF.</p>\n<p>“We believe that Pinduoduo's important role in modernizing China’s agriculture industry and alleviating poverty across Tier 2 and 3 cities is improving its relationship with the Chinese government relative to its competition,” Ark wrote in a note.</p>\n<p>With global demand for food on the rise, it makes sense that Wood would expect an agricultural play to pay off over the long run. But Ark’s investment in Pinduoduo is already paying off: The company’s stock is up almost 16% since Aug. 3.</p>\n<p><b>Unleash your inner Cathie</b></p>\n<p>Whether you see Chinese tech stocks as a short-term value play or a long-term investment in a sector too crucial to be over-regulated, you’ll need to get started somewhere.</p>\n<p>You’re probably already familiar with popular no-fee investment platforms, but there are several other digital platforms you can use to put your money to work.</p>\n<p>One even allows you to invest in a diversified portfolio using little more than the “spare change” left over from your everyday purchases.</p>\n<p>However you choose to invest your money, especially when it comes to volatile assets like Chinese tech stocks, just make sure you’re making an informed decision — one you can afford — and not just chasing the next flash in the pan.</p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood is pouring millions into these China tech stocks — time to follow?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood is pouring millions into these China tech stocks — time to follow?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-05 01:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/cathie-wood-pouring-millions-china-174500701.html><strong>MoneyWise</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It’s been a whiplash 2021 for Chinese tech stocks.\nThe Nasdaq Golden Dragon China Index, which tracks 98 of the biggest Chinese companies listed in the U.S., hit a record high of 20,688 on Feb. 12. ...</p>\n\n<a href=\"https://finance.yahoo.com/news/cathie-wood-pouring-millions-china-174500701.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKF":"ARK Fintech Innovation ETF","JD":"京东","PDD":"拼多多","CAAS":"中汽系统","ARKQ":"ARK Autonomous Technology & Robotics ETF"},"source_url":"https://finance.yahoo.com/news/cathie-wood-pouring-millions-china-174500701.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2164808914","content_text":"It’s been a whiplash 2021 for Chinese tech stocks.\nThe Nasdaq Golden Dragon China Index, which tracks 98 of the biggest Chinese companies listed in the U.S., hit a record high of 20,688 on Feb. 12. But the index has been walloped since then on concerns that China’s tech sector could soon be facing greater scrutiny and tighter regulations at the hands of the Chinese government.\nCathie Wood, founder of Ark Invest, one of the planet’s most hyped investment management firms, was one of the many investors to dump her Chinese stocks in late July.\nWood has since returned to the Chinese tech space, bolstering her company's holdings with several notable Chinese stocks.\nLet’s see which stocks received the ace investor's stamp of approval this time around.\nJD.com (JD)\nWood made multiple purchases of JD.com stock in August, nabbing 59,000 shares of the e-commerce company to the Ark Fintech Innovation ETF (ARKF) and just under 165,000 for Ark’s Autonomous Technology and Robotics ETF (ARKQ).\n\"I'm not pessimistic about China in the longer run because I think they're a very entrepreneurial society,\" Wood told Bloomberg. \"Sure, the government is putting more rules and regulations in, but I don't think the government wants to stop growth and progress at all.\"\nIt’s an interesting take, considering Wood said during a recent Ark webinar with investors that Chinese stocks “probably will remain down.\"\nBut Wood obviously sees value in JD.com after the company reported a 26% increase in revenue and a 27% increase in its user base during the second quarter of 2021. It’s stock has risen more than 12% in the past month.\nAs one of the largest retailers in China, JD.com provides companies access to one of the world’s largest cohorts of consumers. The firm’s revenue streams are bolstered by offering marketing, analytics, logistics and warehousing and financing services.\nTencent (TCEHY)\nOn Aug. 16, Ark dumped more than 171,000 shares in Chinese tech conglomerate Tencent. A little more than a week later, Wood snapped up almost 235,000 shares in the company and added them to ARKF. Tencent now makes up 1.24% of ARKF’s holdings.\nIt’s been a rough few months for Tencent. The company was recently fined multiple times by the Chinese government for anti-competitive behavior and saw its share price fall by more than 30% in the last six months. Company president Martin Lau recently told investors that he expects government regulators to be quite busy cracking down on the country’s tech sector.\n“It will be coming from all different regulator entities,” Lau said during an Aug. 18 call. “We think that there will be quite a few [new measures] coming out.”\nBut Tencent’s exposure to multiple growth industries, including video games, cloud computing and artificial intelligence, make it an intriguing bet for funds like ARKF. Impressive second quarter results — a year over year increase in net profit of 29%, a rise in fintech and business services revenue of 40% — brought investors flocking back to buy Tencent on the dip.\nSince Aug. 19, Tencent stock is up almost 18%.\nPinduoduo (PDD)\nAscannio / Shutterstock\nThe largest agriculture-focused tech platform in China, Pinduoduo currently connects about 12 million farmers and distributors directly to consumers. The company recently pledged to invest approximately $1.5 billion into advancing agricultural technology for the country’s farmers.\nBetween Pinduoduo’s business model and socially-conscious goals, Ark Invest appears to see a bright future for the company. In four transactions at the end of August, Ark added almost 208,000 shares to ARKF.\n“We believe that Pinduoduo's important role in modernizing China’s agriculture industry and alleviating poverty across Tier 2 and 3 cities is improving its relationship with the Chinese government relative to its competition,” Ark wrote in a note.\nWith global demand for food on the rise, it makes sense that Wood would expect an agricultural play to pay off over the long run. But Ark’s investment in Pinduoduo is already paying off: The company’s stock is up almost 16% since Aug. 3.\nUnleash your inner Cathie\nWhether you see Chinese tech stocks as a short-term value play or a long-term investment in a sector too crucial to be over-regulated, you’ll need to get started somewhere.\nYou’re probably already familiar with popular no-fee investment platforms, but there are several other digital platforms you can use to put your money to work.\nOne even allows you to invest in a diversified portfolio using little more than the “spare change” left over from your everyday purchases.\nHowever you choose to invest your money, especially when it comes to volatile assets like Chinese tech stocks, just make sure you’re making an informed decision — one you can afford — and not just chasing the next flash in the pan.","news_type":1},"isVote":1,"tweetType":1,"viewCount":929,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":815368327,"gmtCreate":1630645424869,"gmtModify":1676530365259,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582597737343890","authorIdStr":"3582597737343890"},"themes":[],"htmlText":"Palantir is long term","listText":"Palantir is long term","text":"Palantir is long term","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/815368327","repostId":"1129167710","repostType":4,"isVote":1,"tweetType":1,"viewCount":907,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":832634585,"gmtCreate":1629617471047,"gmtModify":1676530080837,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582597737343890","authorIdStr":"3582597737343890"},"themes":[],"htmlText":"Is it time to accumulate Baba?","listText":"Is it time to accumulate Baba?","text":"Is it time to accumulate Baba?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/832634585","repostId":"1133515985","repostType":4,"isVote":1,"tweetType":1,"viewCount":220,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":895408617,"gmtCreate":1628761623739,"gmtModify":1676529845787,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582597737343890","authorIdStr":"3582597737343890"},"themes":[],"htmlText":"Not an encouraging debut","listText":"Not an encouraging debut","text":"Not an encouraging debut","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/895408617","repostId":"1145397172","repostType":4,"isVote":1,"tweetType":1,"viewCount":384,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3577178099298017","authorId":"3577178099298017","name":"DragonKC","avatar":"https://static.tigerbbs.com/f90c63c67a4e5f91e9dc0159f5b853ab","crmLevel":1,"crmLevelSwitch":0,"idStr":"3577178099298017","authorIdStr":"3577178099298017"},"content":"Desperate for funding.","text":"Desperate for funding.","html":"Desperate for funding."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":812377169,"gmtCreate":1630558149851,"gmtModify":1676530340172,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582597737343890","authorIdStr":"3582597737343890"},"themes":[],"htmlText":"It's about time","listText":"It's about time","text":"It's about time","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/812377169","repostId":"1105808841","repostType":4,"repost":{"id":"1105808841","kind":"news","pubTimestamp":1630547089,"share":"https://ttm.financial/m/news/1105808841?lang=&edition=full_marsco","pubTime":"2021-09-02 09:44","market":"hk","language":"en","title":"Hong Kong: Shares extend gains at open","url":"https://stock-news.laohu8.com/highlight/detail?id=1105808841","media":"AFP","summary":"[HONG KONG] Hong Kong stocks began with another advance on Thursday morning as investors bide their ","content":"<p>[HONG KONG] Hong Kong stocks began with another advance on Thursday morning as investors bide their time ahead of the release of key US jobs data at the end of the week.</p>\n<p>The Hang Seng Index rose 0.67 per cent or 175.23 points to 26,203.52.</p>\n<p>The Shanghai Composite dipped 0.20 per cent or 7.20 points to 3,559.90, while the Shenzhen Composite Index on China's second exchange fell 0.22 per cent or 5.32 points to 2,412.57.</p>","source":"lsy1605843958005","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong: Shares extend gains at open</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong: Shares extend gains at open\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-02 09:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.businesstimes.com.sg/stocks/hong-kong-shares-extend-gains-at-open-3><strong>AFP</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>[HONG KONG] Hong Kong stocks began with another advance on Thursday morning as investors bide their time ahead of the release of key US jobs data at the end of the week.\nThe Hang Seng Index rose 0.67 ...</p>\n\n<a href=\"https://www.businesstimes.com.sg/stocks/hong-kong-shares-extend-gains-at-open-3\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HSI":"恒生指数"},"source_url":"https://www.businesstimes.com.sg/stocks/hong-kong-shares-extend-gains-at-open-3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105808841","content_text":"[HONG KONG] Hong Kong stocks began with another advance on Thursday morning as investors bide their time ahead of the release of key US jobs data at the end of the week.\nThe Hang Seng Index rose 0.67 per cent or 175.23 points to 26,203.52.\nThe Shanghai Composite dipped 0.20 per cent or 7.20 points to 3,559.90, while the Shenzhen Composite Index on China's second exchange fell 0.22 per cent or 5.32 points to 2,412.57.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1393,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818218789,"gmtCreate":1630412879541,"gmtModify":1676530296020,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582597737343890","authorIdStr":"3582597737343890"},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/818218789","repostId":"1134100855","repostType":4,"isVote":1,"tweetType":1,"viewCount":1278,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":818218568,"gmtCreate":1630412868854,"gmtModify":1676530296003,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582597737343890","authorIdStr":"3582597737343890"},"themes":[],"htmlText":"That's great","listText":"That's great","text":"That's great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/818218568","repostId":"1134100855","repostType":4,"isVote":1,"tweetType":1,"viewCount":1371,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":835268267,"gmtCreate":1629721516759,"gmtModify":1676530110802,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582597737343890","authorIdStr":"3582597737343890"},"themes":[],"htmlText":"Accumulate","listText":"Accumulate","text":"Accumulate","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/835268267","repostId":"1102999278","repostType":4,"repost":{"id":"1102999278","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1629721328,"share":"https://ttm.financial/m/news/1102999278?lang=&edition=full_marsco","pubTime":"2021-08-23 20:22","market":"us","language":"en","title":"Vivos Therapeutics Stock Is Moving Higher On FDA Approval For Its Sleep Apnea Device","url":"https://stock-news.laohu8.com/highlight/detail?id=1102999278","media":"Benzinga","summary":"The FDA has granted 510(k) clearance to Vivos Therapeutics Inc's mmRNA (modified mandibular Repositi","content":"<p>The&nbsp;FDA has granted 510(k) clearance&nbsp;to&nbsp;<b><a href=\"https://laohu8.com/S/VVOS\">Vivos Therapeutics</a> Inc's</b>&nbsp;mmRNA (modified mandibular Repositioning Nighttime Appliance) obstructive sleep apnea (OSA) device.</p>\n<p>The device is indicated for mild to moderate OSA, sleep-disordered breathing, and snoring in adults.</p>\n<p>The approval paves the way for expanded insurance reimbursement coverage for the mmRNA device and potential future government contracts and reimbursement.</p>\n<p>Separately, the FDA has denied Vivos' previously submitted, additional 510(k) application for its DNA appliance.</p>\n<p>The DNA appliance is already registered with the FDA as a Class I device for palatal expansion and is currently being used by Vivos-trained clinicians accordingly.</p>\n<p>Vivos expects to appeal the FDA's decision or resubmit the 510(k) application to the FDA in the coming weeks.</p>\n<p><b>Price Action:</b>&nbsp;VVOS shares are up 41.9% at $5.45 during the premarket session on the last check Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vivos Therapeutics Stock Is Moving Higher On FDA Approval For Its Sleep Apnea Device</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVivos Therapeutics Stock Is Moving Higher On FDA Approval For Its Sleep Apnea Device\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-08-23 20:22</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>The&nbsp;FDA has granted 510(k) clearance&nbsp;to&nbsp;<b><a href=\"https://laohu8.com/S/VVOS\">Vivos Therapeutics</a> Inc's</b>&nbsp;mmRNA (modified mandibular Repositioning Nighttime Appliance) obstructive sleep apnea (OSA) device.</p>\n<p>The device is indicated for mild to moderate OSA, sleep-disordered breathing, and snoring in adults.</p>\n<p>The approval paves the way for expanded insurance reimbursement coverage for the mmRNA device and potential future government contracts and reimbursement.</p>\n<p>Separately, the FDA has denied Vivos' previously submitted, additional 510(k) application for its DNA appliance.</p>\n<p>The DNA appliance is already registered with the FDA as a Class I device for palatal expansion and is currently being used by Vivos-trained clinicians accordingly.</p>\n<p>Vivos expects to appeal the FDA's decision or resubmit the 510(k) application to the FDA in the coming weeks.</p>\n<p><b>Price Action:</b>&nbsp;VVOS shares are up 41.9% at $5.45 during the premarket session on the last check Monday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VVOS":"Vivos Therapeutics"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102999278","content_text":"The FDA has granted 510(k) clearance to Vivos Therapeutics Inc's mmRNA (modified mandibular Repositioning Nighttime Appliance) obstructive sleep apnea (OSA) device.\nThe device is indicated for mild to moderate OSA, sleep-disordered breathing, and snoring in adults.\nThe approval paves the way for expanded insurance reimbursement coverage for the mmRNA device and potential future government contracts and reimbursement.\nSeparately, the FDA has denied Vivos' previously submitted, additional 510(k) application for its DNA appliance.\nThe DNA appliance is already registered with the FDA as a Class I device for palatal expansion and is currently being used by Vivos-trained clinicians accordingly.\nVivos expects to appeal the FDA's decision or resubmit the 510(k) application to the FDA in the coming weeks.\nPrice Action: VVOS shares are up 41.9% at $5.45 during the premarket session on the last check Monday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":348,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":891978491,"gmtCreate":1628325132013,"gmtModify":1703505104843,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582597737343890","authorIdStr":"3582597737343890"},"themes":[],"htmlText":"Go for the leaders in the industry","listText":"Go for the leaders in the industry","text":"Go for the leaders in the industry","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/891978491","repostId":"1143051031","repostType":4,"isVote":1,"tweetType":1,"viewCount":293,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":899137704,"gmtCreate":1628168090308,"gmtModify":1703502428347,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582597737343890","authorIdStr":"3582597737343890"},"themes":[],"htmlText":"I am bullish on Apple and Visa","listText":"I am bullish on Apple and Visa","text":"I am bullish on Apple and Visa","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/899137704","repostId":"2157343182","repostType":4,"isVote":1,"tweetType":1,"viewCount":364,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":802581303,"gmtCreate":1627788293102,"gmtModify":1703495881109,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582597737343890","authorIdStr":"3582597737343890"},"themes":[],"htmlText":"Keep your cash for now","listText":"Keep your cash for now","text":"Keep your cash for now","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/802581303","repostId":"1142925544","repostType":4,"isVote":1,"tweetType":1,"viewCount":291,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":803757727,"gmtCreate":1627467403869,"gmtModify":1703490517610,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582597737343890","authorIdStr":"3582597737343890"},"themes":[],"htmlText":"Buy for long term","listText":"Buy for long term","text":"Buy for long term","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/803757727","repostId":"1103651114","repostType":4,"isVote":1,"tweetType":1,"viewCount":136,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":151026006,"gmtCreate":1625059054305,"gmtModify":1703735039959,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582597737343890","authorIdStr":"3582597737343890"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/151026006","repostId":"1195094821","repostType":4,"isVote":1,"tweetType":1,"viewCount":228,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":891489583,"gmtCreate":1628411316142,"gmtModify":1703506016367,"author":{"id":"3582597737343890","authorId":"3582597737343890","name":"YeeMeng","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3582597737343890","authorIdStr":"3582597737343890"},"themes":[],"htmlText":"I am bullish on Tesla","listText":"I am bullish on Tesla","text":"I am bullish on Tesla","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/891489583","repostId":"1159872041","repostType":4,"isVote":1,"tweetType":1,"viewCount":209,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}